Home › Compare › CFFMF vs MRK

CFFMF vs MRK: Dividend Comparison 2026

CFFMF yields 153846.15% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CFFMF wins by $3.570817397657267e+28M in total portfolio value
10 years
CFFMF
CFFMF
● Live price
153846.15%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.570817397657267e+28M
Annual income
$35,662,574,083,913,823,000,000,000,000,000,000.00
Full CFFMF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — CFFMF vs MRK

📍 CFFMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCFFMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CFFMF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CFFMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CFFMF
Annual income on $10K today (after 15% tax)
$13,076,923.08/yr
After 10yr DRIP, annual income (after tax)
$30,313,187,971,326,747,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, CFFMF beats the other by $30,313,187,971,326,747,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CFFMF + MRK for your $10,000?

CFFMF: 50%MRK: 50%
100% MRK50/50100% CFFMF
Portfolio after 10yr
$1.7854086988286334e+28M
Annual income
$17,831,287,041,956,911,000,000,000,000,000,000.00/yr
Blended yield
99.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CFFMF
No analyst data
Altman Z
11.8
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CFFMF buys
0
MRK buys
0
No recent congressional trades found for CFFMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCFFMFMRK
Forward yield153846.15% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$3.570817397657267e+28M$30.7K ✓
Annual income after 10y$35,662,574,083,913,823,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$3.5705187474861104e+28M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CFFMF vs MRK ($10,000, DRIP)

YearCFFMF PortfolioCFFMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,395,315$15,384,615.38$11,192$351.54+$15.38M → CFFMF
2$22,152,081,017$22,135,608,029.64$12,524$392.70+$22152.07M → CFFMF
3$29,790,603,453,124$29,766,900,726,435.82$14,015$438.65+$29790603.44M → CFFMF
4$37,444,193,407,360,220$37,412,317,461,665,380.00$15,682$489.96+$37444193407.34M → CFFMF
5$43,987,751,239,956,050,000$43,947,685,953,010,180,000.00$17,547$547.23+$43987751239956.04M → CFFMF
6$48,297,311,048,679,450,000,000$48,250,244,154,852,700,000,000.00$19,632$611.16+$48297311048679448.00M → CFFMF
7$49,563,274,505,183,440,000,000,000$49,511,596,382,361,350,000,000,000.00$21,963$682.53+$49563274505183444992.00M → CFFMF
8$47,538,442,557,656,110,000,000,000,000$47,485,409,853,935,560,000,000,000,000.00$24,571$762.18+$4.753844255765611e+22M → CFFMF
9$42,616,722,111,071,980,000,000,000,000,000$42,565,855,977,535,280,000,000,000,000,000.00$27,486$851.08+$4.261672211107198e+25M → CFFMF
10$35,708,173,976,572,667,000,000,000,000,000,000$35,662,574,083,913,823,000,000,000,000,000,000.00$30,745$950.29+$3.570817397657267e+28M → CFFMF

CFFMF vs MRK: Complete Analysis 2026

CFFMF — Stock

CFOAM Limited, through its subsidiary, CFOAM LLC, produces and sells carbon foam products in the United States. The company offers CFOAM carbon foam products, which are inorganic carbon materials manufactured from coal, pitch, or lignin feedstock. Its carbon foam products are used in various markets, including energy absorbing, aerospace tooling, fireproof wall core material, energy absorbing structures, blast protection systems, exhaust systems, and hot structures, as well as thermal protection systems, and structural panels for EMI shielding and RADAR-absorbing application. The company was incorporated in 2016 and is based in West Perth, Australia.

Full CFFMF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this CFFMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CFFMF vs SCHDCFFMF vs JEPICFFMF vs OCFFMF vs KOCFFMF vs MAINCFFMF vs JNJCFFMF vs ABBVCFFMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.